ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes.

Yu-Jie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.